Human Milk Oligosaccharides Infant Formula Inflammation Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current infant formulas lack the ability to effectively modulate inflammation and enhance immunity against microbial infections, particularly in preterm and term infants, due to the immaturity of their immune systems and the absence of breast milk, which contains essential anti-inflammatory and immune-modulating components.
Innovation Solution
Development of nutritional compositions, including synthetic infant and pediatric formulas, that incorporate human milk oligosaccharides (HMOs) such as 6′-sialyllactose, 2′-fucosyllactose, and lacto-N-neotetraose, combined with long chain polyunsaturated fatty acids, antioxidants, and nucleotides, to reduce inflammation and enhance immune function.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If infant formulas are designed to provide basic nutrition, then nutritional needs are met, but the ability to modulate inflammation and enhance immunity is insufficient
Solution Approach 1:
The patent combines multiple bioactive components (HMOs, antioxidants, anti-inflammatory agents) into a composite nutritional composition that provides both basic nutrition and immune-modulating functions. This composite approach allows the formula to simultaneously meet nutritional needs while enhancing immune response and reducing inflammation, thereby resolving the contradiction between reliability of immune function and adaptability to inflammatory conditions.
Solution Approach 2:
The nutritional composition is designed to perform multiple functions: providing basic nutrition, modulating inflammation, enhancing immunity, and protecting against oxidative stress. By making the formula multi-functional, it can adapt to various immune challenges and inflammatory conditions while maintaining reliable nutritional support, thus resolving the contradiction between these competing requirements.
2Reliability
If breast milk components are used to enhance immune function, then inflammation modulation improves, but the complexity of the composition increases
Solution Approach 1:
The patent extracts and isolates specific bioactive components (HMOs, antioxidants, anti-inflammatory agents) from breast milk and concentrates them in the nutritional formula. This extraction approach allows the formula to provide the immune-modulating benefits of breast milk components without requiring the entire complex breast milk composition, thereby improving inflammation regulation while managing composition complexity.
Solution Approach 2:
The patent modifies the concentration and composition ratios of bioactive components in the formula to optimize immune function. By carefully controlling the parameters of HMO types, antioxidant levels, and anti-inflammatory agent dosages, the formula achieves reliable inflammation regulation while maintaining a manageable composition structure that can be manufactured and standardized.
3Object-affected harmful factors
If multiple bioactive components are added to enhance immunity, then protective effects improve, but the manufacturing process becomes more difficult
Solution Approach 1:
The patent incorporates antioxidants and anti-inflammatory agents into the formula during the manufacturing process before final packaging. This preliminary action ensures that the bioactive components are already present and distributed uniformly in the finished product, providing protection against oxidative stress and infection without requiring complex post-manufacturing processing or special handling procedures.
Solution Approach 2:
The patent combines multiple bioactive components (HMOs, antioxidants, anti-inflammatory agents) into a single integrated nutritional formula that can be manufactured using standard infant formula production processes. By merging these components into one composition, the formula provides comprehensive protection while avoiding the need for separate manufacturing steps for each ingredient, thereby maintaining ease of manufacture.
Data Source
AI summary
Disclosed are methods of reducing the incidence of oxidative stress in infants, toddlers, and children using nutritional compositions including human milk oligosaccharides. The nutritional compositions including the human milk oligosaccharides are effective at reducing inflammation and the incidence of inflammatory diseases.